Moderna Inc. on June 1 filed for full U.S. approval of the company’s Covid-19 vaccine, becoming the second drugmaker to do so after Pfizer Inc. and its German partner BioNTech SE sought full clearance for their vaccine in May.
https://www.pharmalive.com/wp-content/uploads/2021/06/Moderna-files-for-full-U.S.-approval-of-COVID-19-vaccine-Reuters-6-1-21.jpg503960Andrew Humphreyshttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAndrew Humphreys2021-06-01 09:59:132021-06-01 13:00:49Moderna files for full U.S. approval of Covid-19 vaccine